ProQR Therapeutics (PRQR) Return on Equity (2018 - 2023)

ProQR Therapeutics' Return on Equity history runs 6 years deep, the most recent figure standing at 0.01% for Q4 2023.

• In Q4 2023, Return on Equity changed 0.0% year-over-year to 0.01%; the TTM figure through Dec 2023 stood at 0.01% (changed 0.0% YoY), while the FY2025 annual figure was 0.01%, changed 0.0% from the prior year.
• Return on Equity came in at 0.01% for Q4 2023 at ProQR Therapeutics, up from 0.01% in the prior quarter.
• In the past five years, Return on Equity ranged from a high of 0.0% in Q3 2021 to a low of 0.01% in Q1 2021.
• A 5-year average of 0.01% and a median of 0.01% in 2023 frame the typical range for Return on Equity.
• Across the five-year window, Return on Equity tumbled 1718 bps in 2019 and increased 1 bps in 2020, its largest moves.
• ProQR Therapeutics' Return on Equity stood at 0.01% in 2019, then advanced by 13 bps to 0.01% in 2020, then rose by 27 bps to 0.0% in 2021, then tumbled by 115 bps to 0.01% in 2022, then climbed by 30 bps to 0.01% in 2023.
• According to Business Quant data, Return on Equity over the past three periods registered 0.01%, 0.01%, and 0.01% for Q4 2023, Q3 2023, and Q2 2023 respectively.

Peer Comparison